Artificial bone will lead bone defect repair materials sales through 2036 with 40.0% of the type segment in 2026. The market was valued at USD 2.60 billion in 2025 and is expected to be worth USD 9.59 billion by 2036, creating an incremental opportunity of USD 6.66 billion.